Can Multiple Myeloma Cause Elevated Band Neutrophils?
Multiple myeloma itself does not directly cause elevated band neutrophils (bandemia) on CBC, but bandemia in myeloma patients typically indicates a secondary bacterial infection, which is a major complication of the disease. 1
Understanding the Relationship
Why Myeloma Patients Develop Infections Leading to Bandemia
Myeloma patients have a 7-fold higher risk of bacterial infections compared to age-matched healthy individuals, making infection the leading cause of death in 22% of myeloma patients at one year. 1
The increased infection susceptibility results from myeloma-related immunodeficiency involving B-cell dysfunction, functional abnormalities of dendritic cells, T-cells, and NK cells, not from direct bone marrow infiltration causing bandemia. 1
Functional hypogammaglobulinemia is characteristic of myeloma—total immunoglobulin may be elevated, but the antibody repertoire is restricted, leading to recurrent sinopulmonary infections. 1
Common Pathogens Causing Bandemia in Myeloma
Streptococcus pneumoniae, Haemophilus influenzae, and Gram-negative bacilli are the most frequent bacterial causes of infection in myeloma patients. 1
These infections trigger the bone marrow to release immature neutrophils (bands) into circulation, producing the bandemia seen on CBC. 1
What CBC Actually Shows in Myeloma
Direct Myeloma Effects on CBC
Anemia is present in approximately 75% of patients at diagnosis—normochromic, normocytic with hemoglobin <10 g/dL or ≥2 g/dL below normal. 1, 2
Neutropenia can occur from bone marrow infiltration by plasma cells or from treatment (16-66% depending on regimen), but this is neutropenia, not bandemia. 1
Thrombocytopenia may be present but is less common than anemia. 1
When to Suspect Infection vs. Myeloma Progression
Elevated bands with fever, leukocytosis, or neutrophilia strongly suggests acute bacterial infection requiring immediate broad-spectrum antibiotics. 1
Pancytopenia without bandemia suggests bone marrow infiltration by myeloma or treatment-related myelosuppression. 1
Anemia with normal or low white count is the typical CBC pattern of untreated myeloma itself. 2, 3
Clinical Pitfalls to Avoid
Do not attribute bandemia to myeloma itself—always investigate for infection, as this is a medical emergency in immunocompromised myeloma patients. 1
Neutropenia from treatment (especially lenalidomide, melphalan-based regimens) increases infection risk further, with 16-66% experiencing neutropenia depending on the specific regimen. 1
Recurrent infections are a presenting symptom of myeloma in some patients, so new-onset bandemia in an older adult with unexplained anemia or bone pain should prompt evaluation for both infection AND underlying myeloma. 2, 4
Management Implications
Antibiotic prophylaxis should be considered for the first three months of therapy with lenalidomide or pomalidomide, particularly in patients with aggressive disease, history of infections, or neutropenia. 1
Vaccination against Streptococcus pneumoniae, Haemophilus influenzae, and influenza is recommended, though efficacy may be suboptimal due to impaired immune response. 1
Broad-spectrum antibiotics are required for any febrile illness in myeloma patients, regardless of band count. 1